Orthocell (ASX:OCC) EPS (Basic) : A$-0.04 (TTM As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Orthocell EPS (Basic)?

Orthocell's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was A$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.04.

Orthocell's EPS (Diluted) for the six months ended in Jun. 2024 was A$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.04.

Orthocell's EPS without NRI for the six months ended in Jun. 2024 was A$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.04.

During the past 3 years, the average EPS without NRI Growth Rate was 8.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Orthocell's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was -4.50% per year. And the median was 4.50% per year.

Orthocell EPS (Basic) Historical Data

The historical data trend for Orthocell's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthocell EPS (Basic) Chart

Orthocell Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

-0.04

-0.05

-0.03

-0.04

Orthocell Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial															-0.02	-0.02	-0.01	-0.03	-0.01

Orthocell EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Orthocell's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-7.181	-	0)	/	202.008
	=	-0.04

Orthocell's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.951	-	0)	/	202.008
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.04

Orthocell (ASX:OCC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Orthocell EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Orthocell's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150

Website

https://www.orthocell.com.au

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir which is a collagen wrap used in peripheral nerve repair; and OrthoACI an implantation used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline such as Tendon Cell Therapy and Collagen Medical Device Platform.